Millennium Management’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Millennium Management’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-37,160	Closed	-$42K	–	7875
2022 Q2	$42K	Buy	37,160 +19,732	+113%	+$32.5K	﹤0.01%	6260
2022 Q1	$89K	Sell	17,428 -17,343	-50%	-$109K	﹤0.01%	6201
2021 Q4	$196K	Sell	34,771 -8,571	-20%	-$72.9K	﹤0.01%	5921
2021 Q3	$480K	Sell	43,342 -201,229	-82%	-$2.53M	﹤0.01%	5391
2021 Q2	$4.14M	Buy	244,571 +221,239	+948%	+$4.19M	﹤0.01%	3005
2021 Q1	$612K	Buy	23,332 +3,401	+17%	+$155K	﹤0.01%	4654
2020 Q4	$720K	Buy	19,931 +18,704	+1,524%	+$676K	﹤0.01%	3948
2020 Q3	$43	Sell	1,227 -117,341	-99%	-$5.1M	﹤0.01%	4306
2020 Q2	$5.03M	Buy	+118,568	New	+$7.99M	0.01%	1763
2019 Q4	–	Sell	-1,057	Closed	-$79K	–	4785
2019 Q3	$79K	Buy	+1,057	New	+$81.2K	﹤0.01%	3994
2019 Q2	–	Sell	-6,886	Closed	-$362K	–	4646
2019 Q1	$362K	Sell	6,886 -310	-4%	-$16.8K	﹤0.01%	3445
2018 Q4	$452K	Sell	7,196 -4,511	-39%	-$248K	﹤0.01%	3027
2018 Q3	$711K	Sell	11,707 -37,211	-76%	-$1.61M	﹤0.01%	3058
2018 Q2	$1.99M	Buy	48,918 +48,177	+6,502%	+$3.79M	﹤0.01%	2407
2018 Q1	$71K	Buy	+741	New	+$95.1K	﹤0.01%	3512
2017 Q2	–	Sell	-124	Closed	-$18K	–	4012
2017 Q1	$18K	Buy	+124	New	+$16.1K	﹤0.01%	3429
2015 Q2	–	Sell	-406	Closed	-$300K	–	4004
2015 Q1	$300K	Sell	406 -6	-1%	-$3.83K	﹤0.01%	3045
2014 Q4	$278K	Buy	+412	New	+$311K	﹤0.01%	3400

Other funds holding EVFM

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

AWM

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Millennium Management's EVFM Position: Q3 2022 in Review

Millennium Management sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q3 2022, closing a stake of 37,160 shares — an estimated $42K sold.

Millennium Management first reported a position in EVFM in Q4 2014 and held it in 18 quarters. The position peaked at $5.03M in Q2 2020. 8 funds tracked by Wall St. Rank hold EVFM as of Q3 2022.

Millennium Management reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Millennium Management sold 37,160 Evofem Biosciences, Inc. Common Stock shares in Q3 2022, an estimated $42K.
Millennium Management first reported a position in Evofem Biosciences, Inc. Common Stock in Q4 2014 and held it in 18 quarters.
Millennium Management's Evofem Biosciences, Inc. Common Stock position peaked at $5.03M in Q2 2020.
8 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2022.

Based on Millennium Management's 13F filing for Q3 2022, filed 14 Nov 2022.